SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas is a paper indexed in ScholarIQ from OpenAlex.
How many citations does SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas have?
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas has 956 citations in the OpenAlex counts ScholarIQ stores.
When was SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas published?
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas has 2009 year in the ScholarIQ index.
What is the open-access status of SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas?
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas has green oa status in the ScholarIQ index.
What is the DOI of SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas?
The DOI for SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas is on the source record.
What is the PMID of SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas?
The PMID for SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas is on the source record.
What is the OpenAlex record for SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas?
The OpenAlex for SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas is on the source record.